These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20557670)

  • 1. The expression of LMO2 protein in acute B-cell and myeloid leukemia.
    Cobanoglu U; Sonmez M; Ozbas HM; Erkut N; Can G
    Hematology; 2010 Jun; 15(3):132-4. PubMed ID: 20557670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of LMO2 protein expression on survival in chronic myeloid leukemia patients treated with imatinib mesylate.
    Sonmez M; Akagun T; Cobanoglu U; Topbas M; Erkut N; Yilmaz M; Ovali E; Omay SB
    Hematology; 2009 Aug; 14(4):220-3. PubMed ID: 19635185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype.
    Patel JL; Pournazari P; Haggstrom SJ; Kosari F; Shabani-Rad MT; Natkunam Y; Mansoor A
    Histopathology; 2014 Jan; 64(2):226-33. PubMed ID: 24330148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo Acute Myeloid Leukemia in Adults: Suppression of MicroRNA-223 is Independent of LMO2 Protein Expression BUT Associate With Adverse Cytogenetic Profile and Undifferentiated Blast Morphology.
    Akhter A; Patel JL; Farooq F; Qureshi A; Taher-Rad MS; Elyamany G; Al-Zahrani AM; Rashid-Kolvear F; Mansoor A
    Appl Immunohistochem Mol Morphol; 2015; 23(10):733-9. PubMed ID: 25710580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
    Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
    Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy.
    Pike-Overzet K; de Ridder D; Weerkamp F; Baert MR; Verstegen MM; Brugman MH; Howe SJ; Reinders MJ; Thrasher AJ; Wagemaker G; van Dongen JJ; Staal FJ
    Leukemia; 2007 Apr; 21(4):754-63. PubMed ID: 17268520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Abnormal expression of transcription factors LYL1 and LMO2 and interaction between them in myeloid leukemia].
    Meng YS; Wei R; Ai GW; Meng XQ; Zhang YX
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):890-3. PubMed ID: 19671288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal translocations and leukaemia: a role for LMO2 in T cell acute leukaemia, in transcription and in erythropoiesis.
    Rabbitts TH; Axelson H; Forster A; Grutz G; Lavenir I; Larson R; Osada H; Valge-Archer V; Wadman I; Warren A
    Leukemia; 1997 Apr; 11 Suppl 3():271-2. PubMed ID: 9209362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia.
    Van Vlierberghe P; Beverloo HB; Buijs-Gladdines J; van Wering ER; Horstmann M; Pieters R; Meijerink JP
    Leukemia; 2008 Jul; 22(7):1434-7. PubMed ID: 18079736
    [No Abstract]   [Full Text] [Related]  

  • 10. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
    de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
    Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of DeltaEF1 as a novel target that is negatively regulated by LMO2 in T-cell leukemia.
    Sun W; Yang S; Shen W; Li H; Gao Y; Zhu TH
    Eur J Haematol; 2010 Dec; 85(6):508-19. PubMed ID: 20731704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
    Hirose K; Inukai T; Kikuchi J; Furukawa Y; Ikawa T; Kawamoto H; Oram SH; Göttgens B; Kiyokawa N; Miyagawa Y; Okita H; Akahane K; Zhang X; Kuroda I; Honna H; Kagami K; Goi K; Kurosawa H; Look AT; Matsui H; Inaba T; Sugita K
    Blood; 2010 Aug; 116(6):962-70. PubMed ID: 20519628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal.
    McCormack MP; Young LF; Vasudevan S; de Graaf CA; Codrington R; Rabbitts TH; Jane SM; Curtis DJ
    Science; 2010 Feb; 327(5967):879-83. PubMed ID: 20093438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors.
    Landry JR; Bonadies N; Kinston S; Knezevic K; Wilson NK; Oram SH; Janes M; Piltz S; Hammett M; Carter J; Hamilton T; Donaldson IJ; Lacaud G; Frampton J; Follows G; Kouskoff V; Göttgens B
    Blood; 2009 Jun; 113(23):5783-92. PubMed ID: 19171877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody.
    Agostinelli C; Paterson JC; Gupta R; Righi S; Sandri F; Piccaluga PP; Bacci F; Sabattini E; Pileri SA; Marafioti T
    Histopathology; 2012 Jul; 61(1):33-46. PubMed ID: 22394247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients.
    Oram SH; Thoms JA; Pridans C; Janes ME; Kinston SJ; Anand S; Landry JR; Lock RB; Jayaraman PS; Huntly BJ; Pimanda JE; Göttgens B
    Oncogene; 2010 Oct; 29(43):5796-808. PubMed ID: 20676125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LIM domain protein Lmo2 binds to AF6, a translocation partner of the MLL oncogene.
    Bégay-Müller V; Ansieau S; Leutz A
    FEBS Lett; 2002 Jun; 521(1-3):36-8. PubMed ID: 12067721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel transcript of the LMO2 gene, LMO2-c, is regulated by GATA-1 and PU.1 and encodes an antagonist of LMO2.
    Wang Q; Zhang M; Wang X; Yuan W; Chen D; Royer-Pokora B; Zhu T
    Leukemia; 2007 May; 21(5):1015-25. PubMed ID: 17361224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia.
    Van Vlierberghe P; van Grotel M; Beverloo HB; Lee C; Helgason T; Buijs-Gladdines J; Passier M; van Wering ER; Veerman AJ; Kamps WA; Meijerink JP; Pieters R
    Blood; 2006 Nov; 108(10):3520-9. PubMed ID: 16873670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of microRNA-223 in lymphocytic leukemia cells and its action mechanism].
    Nan Z; Liang Y; Fu R; Liu H; Ruan EB; Wang XM; Wang GJ; Qu W; Liu H; Wu YH; Song J; Xing LM; Guan J; Li LJ; Wang HQ; Shao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):556-61. PubMed ID: 23815897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.